Showing results (561-570 of 652) with videos related to
Sort By:
Pageof 66
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2024
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic ExposureLaurent Peyrin-Biroulet, Remo Panaccione, Edouard Louis, et al.Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.Lancet (London, England)|June 12, 2022
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E Sands, Peter M Irving, Timothy Hoops, et al.ACS Applied Materials & Interfaces|June 15, 2017
Role of Oxygen Deposition Pressure in the Formation of Ti Defect States in TiO<sub>2</sub>(001) Anatase Thin FilmsBenoit Gobaut, Pasquale Orgiani, Alessia Sambri, et al.Journal of the Canadian Association of Gastroenterology|December 5, 2022
Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort StudyCynthia H Seow, Stephanie Coward, Karen I Kroeker, et al.Inflammatory Bowel Diseases|October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.Current Neuropharmacology|May 16, 2017
Neurobiological Evidence for the Primacy of Mania HypothesisGeorgios D Kotzalidis, Chiara Rapinesi, Valeria Savoja, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2026
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 StudiesRemo Panaccione, Julián Panés, Laurent Peyrin-Biroulet, et al.Eclinicalmedicine|November 10, 2025
An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel diseaseVirginia Solitano, Jurij Hanžel, Christopher Ma, et al.Advanced Materials (Deerfield Beach, Fla.)|November 25, 2015
Giant Rashba-Type Spin Splitting in Ferroelectric GeTe(111)Marcus Liebmann, Christian Rinaldi, Domenico Di Sante, et al.Pageof 66